Inactive Instrument

Ardea Biosciences, Inc. Share Price

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2012	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
2012	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE

SANOFI : AstraZeneca hungry to refill medicine cabinet	30/12/30	RE
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	09/12/09	RE
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	02/12/02	RE
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	01/12/01	RE
SANOFI : AstraZeneca CEO quits as drug sales tumble	26/12/26	RE
Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	26/12/26	RE

Ardea Biosciences, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.	01/12/01	PR
Ardea Biosciences, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.	28/12/28	BU
Ardea Biosciences, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.	24/12/24	PR
Ardea Biosciences, Inc. : Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Law Offices of Howard G. Smith	24/12/24	BU
Ardea Biosciences, Inc. : Ryan & Maniskas, LLP Announces Investigation of Ardea Biosciences, Inc.	24/12/24	BU

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B